Rochester, New York 12/1/2009 7:30:00 AM
News / Business

Cornerstone Therapeutics Inc (NASDAQ:CRTX) to Present at Piper Jaffray Health Care Conference December 2

Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) will speak at the Piper Jaffray Health Care Conference on Wednesday, December 2.  The conference will be held at the New York Palace Hotel in New York City.  Cornerstone Therapeutics President and Chief Executive Officer Craig Collard will begin a presentation at 3:30 pm ET that afternoon.  Interested parties may hear a webcast of the presentation on the Investor Relations section of the company’s website www.crtx.com.

 

Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.

 

For more information regarding Investor Relations, contact Evan Smith/Brian Ritchie at 212.850.5600 or evan.smith@fd.com/brian.ritchie@fd.com.  For media enquiries, contact Robert Stanislaro at 212.850.5600 or Robert.stanlislaro@fd.com.

 

Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, developing and commercializing prescription products for the respiratory market. On October 31, 2008, the Company completed the merger with Cornerstone BioPharma. The product development pipeline includes two SPECTRACEF line extensions: a once daily dosage tablet, or SPECTRACEF Once Daily, and an oral suspension for the pediatric market, or SPECTRACEF Suspension. The product development pipeline also includes three additional product candidates: an anticholinergic, or drying agent, and antihistamine combination product candidate for the treatment of symptoms of allergic rhinitis and two antitussive, or cough suppressant, and antihistamine combination product candidates. The SPECTRACEF product line includes SPECTRACEF 200 milligram and SPECTRACEF 400 milligram for the treatment of mild to moderate infections caused by pathogens associated with particular respiratory tract infections.

 

Follow us on Twitter: http://www.twitter.com/pennystockspro

 

Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.

 

About Us

 

Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

 

Please click here to read the full disclaimer.